OSX2:XETRA:XETRA-Ossiam US Minimum Variance ESG NR UCITS ETF 1A (EUR) EUR (EUR)

ETF | Others |

Last Closing

USD 305.25

Change

-0.70 (-0.23)%

Market Cap

USD 0.12B

Volume

15.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.13 (-0.26%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.33%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.08 (-0.30%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.08 (-0.27%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.09 (-0.37%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.41 (-0.90%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

-1.36 (-0.96%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.15 (-0.29%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.10 (-0.09%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.36 (-0.06%)

USD 80.38B

ETFs Containing OSX2:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.03% 80% B- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.03% 80% B- 79% B-
Trailing 12 Months  
Capital Gain 24.72% 74% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.72% 73% C 73% C
Trailing 5 Years  
Capital Gain 45.50% 70% C- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 45.50% 68% D+ 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 7.90% 59% D- 58% F
Dividend Return 7.90% 58% F 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.96% 62% D 70% C-
Risk Adjusted Return 79.33% 75% C 78% C+
Market Capitalization 0.12B 35% F 31% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.